{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:58Z","timestamp":1793066338708,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nmd.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T05:28:28Z","timestamp":1627450108000},"page":"1021-1027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Sarcoglycanopathies: an update"],"prefix":"10.1016","volume":"31","author":[{"given":"Mariz","family":"Vainzof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas S.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Gurgel-Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayana","family":"Zatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.07.014_bib0001","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1468-1331.2007.01979.x","article-title":"EFNS guideline on diagnosis and management of limb girdle muscular dystrophies","volume":"14","author":"Norwood","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(99)00040-4","article-title":"Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population","volume":"164","author":"Vainzof","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2021.07.014_bib0003","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: limb girdle muscular dystrophies \u2013 Nomenclature and reformed classification Naarden, the Netherlands, 17\u201319 March 2017","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.07.014_bib0004","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/oxfordjournals.jbchem.a123276","article-title":"Glycoprotein complex anchoring dystrophin to sarcolemma1","volume":"108","author":"Yoshida","year":"1990","journal-title":"J Biochem"},{"key":"10.1016\/j.nmd.2021.07.014_bib0006","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/mus.1192","article-title":"The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies","volume":"24","author":"Rando","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.07.014_bib0007","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1432-1033.1994.tb18958.x","article-title":"Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside","volume":"222","author":"m","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nmd.2021.07.014_bib0008","doi-asserted-by":"crossref","first-page":"27989","DOI":"10.1074\/jbc.274.39.27989","article-title":"\u03b5-Sarcoglycan replaces \u03b1-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex","volume":"274","author":"Straub","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2021.07.014_bib0009","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.yexcr.2006.03.011","article-title":"\u03b6-Sarcoglycan is a functional homologue of \u03b3-sarcoglycan in the formation of the sarcoglycan complex","volume":"312","author":"Shiga","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.nmd.2021.07.014_bib0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/mus.20349","article-title":"Molecular and cell biology of the sarcoglycan complex","volume":"32","author":"Ozawa","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.07.014_bib0011","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.43.4.795","article-title":"Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma","volume":"43","author":"Ohlendieck","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.07.014_bib0012","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/345315a0","article-title":"Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle","volume":"345","author":"Ervasti","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2021.07.014_bib0013","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/brain\/122.8.1403","article-title":"Making sense of the limb-girdle muscular dystrophies","volume":"122","author":"Bushby","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.014_bib0014","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/hmg\/5.12.1963","article-title":"The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies","volume":"5","author":"Vainzof","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.07.014_bib0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00019052-200010000-00002","article-title":"Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes","volume":"13","author":"Zatz","year":"2000","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1097-0029(20000201\/15)48:3\/4<167::AID-JEMT5>3.0.CO;2-T","article-title":"Sarcoglycans in muscular dystrophy","volume":"48","author":"Hack","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.nmd.2021.07.014_bib0017","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/spen.2002.33795","article-title":"Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies","volume":"9","author":"B\u00f6nnemann","year":"2002","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0018","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<984::AID-MUS24>3.0.CO;2-#","article-title":"Partial \u03b1-sarcoglycan deficiency with retention of the dystrophin- glycoprotein complex in a LGMD2D family","volume":"23","author":"Vainzof","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.07.014_bib0019","first-page":"22","article-title":"Les sarcoglycanopathies","volume":"36","author":"Fern\u00e1ndez-Eulate","year":"2020","journal-title":"M\u00e9d\/Sci"},{"key":"10.1016\/j.nmd.2021.07.014_bib0020","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/WNL.0b013e3181a1885e","article-title":"Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes","volume":"72","author":"Fanin","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.07.014_bib0021","first-page":"207","article-title":"LGMD. identification, description and classification","volume":"39","author":"Angelini","year":"2020","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0022","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/humu.20642","article-title":"Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients","volume":"29","author":"Guglieri","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.07.014_bib0023","first-page":"355","article-title":"Immunological methods for the analydis of protein expression in neuromuscular diseases","volume":"217","author":"Vainzof","year":"2003","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.2.e12","article-title":"Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations","volume":"40","author":"Moreira","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.07.014_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.559327","article-title":"Clinical and genomic evaluation of 207 genetic myopathies in the Indian subcontinent","volume":"11","author":"Chakravorty","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0026","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/humu.23220","article-title":"Exomic variants of an elderly cohort of Brazilians in the ABraOM database","volume":"38","author":"Naslavsky","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2021.07.014_bib0027","article-title":"Whole-genome sequencing of 1,171 elderly admixed individuals from the largest Latin American metropolis (S\u00e3o Paulo, Brazil)","author":"Naslavsky","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.nmd.2021.07.014_bib0028","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/cge.13597","article-title":"Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy","volume":"96","author":"Winckler","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2021.07.014_bib0029","series-title":"Disorders of voluntary muscle","first-page":"230","article-title":"Muscular dystrophies presenting with proximal muscle weakness","author":"Vainzof","year":"2008"},{"key":"10.1016\/j.nmd.2021.07.014_bib0030","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/brain\/awaa228","article-title":"New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy","volume":"143","author":"Alonso-P\u00e9rez","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.014_bib0031","unstructured":"U. Yi\u015f, G. Diniz 2, F. Hazan 3, H.S. Daimag\u00fcler 4 5, B. T. Baysal 6, F. Baydan 2, G. Akinci 6, Aycan \u00dcnalp 6, G\u00fcl Aktan 7, Erhan Bayram 1, Semra Hiz 1, Cem Paket\u00e7i 1, Derya Okur 1, Erdener \u00d6zer 8, Ay\u00e7a Ersen Danyeli 8, Muza S\u00c7 4 5, Expand A. Childhood onset limb-girdle muscular dystrophies in the Aegean part of Turkey 2018:210\u201320."},{"key":"10.1016\/j.nmd.2021.07.014_bib0032","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13023-020-1296-x","article-title":"Mutational spectrum of autosomal recessive limb-girdle muscular dystrophies in a cohort of 112 Iranian patients and reporting of a possible founder effect","volume":"15","author":"Mojbafan","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2021.07.014_bib0033","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.nmd.2017.02.011","article-title":"1st International workshop on clinical trial readiness for sarcoglycanopathies 15\u201316 november","volume":"27","author":"Marsolier","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.07.014_bib0034","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/ijms22052502","article-title":"Muscle diversity, heterogeneity, and gradients: learning from sarcoglycanopathies","volume":"22","author":"S\u00e1nchez Riera","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2021.07.014_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jnnp-2017-316736","article-title":"MRI in sarcoglycanopathies: a large international cohort study","volume":"89","author":"Tasca","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.07.014_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JND-200556","article-title":"Mechanisms and clinical applications of glucocorticoid steroids in muscular dystrophy","volume":"8","author":"Quattrocelli","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2021.07.014_bib0037","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199702273360904","article-title":"Mutations in the sarcoglycan genes in patients with myopathy","volume":"336","author":"Duggan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2021.07.014_bib0038","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ejhg.2008.9","article-title":"Revised spectrum of mutations in sarcoglycanopathies","volume":"16","author":"Trabelsi","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.07.014_bib0039","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/5.12.2019","article-title":"A founder mutation in the \u03b3-sarcoglycan gene of Gypsies possibly predating their migration out of India","volume":"5","author":"Piccolo","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2021.07.014_bib0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00019606-200606000-00006","article-title":"Sarcoglycanopathies: a multiplex molecular analysis for the most common mutations","volume":"15","author":"Gouveia","year":"2006","journal-title":"Diagnostic Mol Pathol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0041","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0960-8966(03)00136-6","article-title":"Phenotype and sarcoglycan expression in Tunisian LGMD 2C patients sharing the same del521-T mutation","volume":"13","author":"Kefi","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.07.014_bib0042","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/1566523220666200218113526","article-title":"Limb-girdle muscular dystrophy and therapy: insights into cell and gene-based approaches","volume":"19","author":"Taheri","year":"2020","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.nmd.2021.07.014_bib0043","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/iep.12095","article-title":"What do mouse models of muscular dystrophy tell us about the DAPC and its components?","volume":"95","author":"Whitmore","year":"2014","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0044","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99357","article-title":"Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers","volume":"3","author":"Wyatt","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.nmd.2021.07.014_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13395-017-0131-0","article-title":"Exome sequencing reveals independent SGCD deletions causing limb girdle muscular dystrophy in Boston terriers","volume":"7","author":"Cox","year":"2017","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.nmd.2021.07.014_bib0046","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13395-020-00257-y","article-title":"Sarcoglycan A mutation in miniature dachshund dogs causes limb-girdle muscular dystrophy 2D","volume":"11","author":"Mickelson","year":"2021","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.nmd.2021.07.014_bib0047","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/hum.2019.199","article-title":"Preclinical systemic delivery of adeno-associated \u03b1-sarcoglycan gene transfer for limb-girdle muscular dystrophy","volume":"32","author":"Griffin","year":"2021","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nmd.2021.07.014_bib0048","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145994","article-title":"Base editing repairs an SGCA mutation in human primary muscle stem cells","volume":"6","author":"Escobar","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.nmd.2021.07.014_bib0049","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ana.21732","article-title":"Limb-girdle muscular dystrophy type 2D gene therapy restores \u03b1-sarcoglycan and associated proteins","volume":"66","author":"Mendell","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.22251","article-title":"Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D","volume":"68","author":"Mendell","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0051","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/brain\/awr342","article-title":"A phase I trial of adeno-associated virus serotype 1-\u03b3-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C","volume":"135","author":"Herson","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.014_bib0052","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2021.07.014_bib0053","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/cge.13544","article-title":"Autosomal recessive limb\u2010girdle and Miyoshi muscular dystrophies in the Netherlands: The clinical and molecular spectrum of 244 patients","volume":"96","author":"ten Dam","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2021.07.014_bib0054","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/01.jnen.0000235854.77716.6c","article-title":"Limb-Girdle Muscular Dystrophy in the United States","volume":"65","author":"Moore","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.nmd.2021.07.014_bib0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13023-019-1021-9","article-title":"Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients","volume":"14","author":"Xie","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:43Z","timestamp":1760775043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0960896621002017"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.07.014","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoglycanopathies: an update","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}